NDC 43528-003-05
HEPLISAV-B 20 ug/.5mL
Hepatitis B Vaccine (Recombinant) Adjuvanted · INJECTION, SOLUTION
Heplisav-B is a vaccine that protects against hepatitis B infection and is given as an injection into the muscle. It is available over-the-counter and uses an adjuvant to help your immune system build stronger protection against the virus.
Key Facts
- Brand Name
- HEPLISAV-B
- Generic Name
- Hepatitis B Vaccine (Recombinant) Adjuvanted
- NDC Code (Package)
43528-003-05- NDC Code (Product)
43528-003- Manufacturer
- Dynavax Technologies Corporation
- Strength
- 20 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125428
- Marketing Start
- 01/01/2018
Recall History
No Recall HistoryView Full Drug Page
HEPLISAV-B — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.